![Sath Nirmalananthan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 2 379 $ as of 2026-09-29
Sath Nirmalananthan is currently a Non-Executive Director at The Institute of Cancer Research: Royal Cancer Hospital and a Member of The Institute of Chartered Accountants in England & Wales.
Former roles include Chief Financial Officer, Secretary & Director at Scancell Holdings Plc from 2024 to 2026, Research Analyst at Nomura International Plc from 2012 to 2013, CFO-Europe, Middle East & Africa at Prenetics Ltd., and Head-Auditor at KPMG UK Ltd. Education includes an undergraduate degree from King's College London.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-04-29 | 19,048 ( 0% ) | 2 379 $ | 2026-09-29 |
| Companies | Position | Start |
|---|---|---|
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Operates as a membership organization for chartered accountant firm and students | Corporate Officer/Principal | - |
The Institute of Cancer Research: Royal Cancer Hospital
 The Institute of Cancer Research: Royal Cancer Hospital Miscellaneous Commercial ServicesCommercial Services Operates as a cancer research institution | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| SCANCELL HOLDINGS PLC | Director of Finance/CFO | 2026-04-23 |
Nomura International Plc
 Nomura International Plc Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2013-02-28 |
KPMG UK Ltd.
 KPMG UK Ltd. Investment ManagersFinance Provides financial advisory services | Comptroller/Controller/Auditor | - |
Prenetics Ltd.
 Prenetics Ltd. Medical/Nursing ServicesHealth Services Provides genetic testing and digital healthcare information services | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 7 |
|---|---|
Nomura International Plc
Nomura International Plc Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Institute of Cancer Research: Royal Cancer Hospital
The Institute of Cancer Research: Royal Cancer Hospital Miscellaneous Commercial ServicesCommercial Services Operates as a cancer research institution | Commercial Services |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Operates as a membership organization for chartered accountant firm and students | Commercial Services |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scancell Holdings Plc
 Scancell Holdings Plc BiotechnologyHealth Technology Develops therapeutic cancer vaccines | Health Technology |
KPMG UK Ltd.
KPMG UK Ltd. Investment ManagersFinance Provides financial advisory services | Finance |
Prenetics Ltd.
Prenetics Ltd. Medical/Nursing ServicesHealth Services Provides genetic testing and digital healthcare information services | Health Services |
Select your edition
All financial news and data tailored to specific country editions
